<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-73735</identifier>
<setSpec>1139-7632</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Since the end of the seventies, many countries started programs on metabolic neonatalscreening focused on early detection and diagnosis of those metabolic congenital disorderswhich, detected in the first days of life, were subject of treatment. Therefore prognosis ofsome of these diseases has improved notably. Initially the programs included the screeningof phenylketonuria and congenital hypothyroidism, being extended later to the detection tocongenital suprarenal hyperplasia and pancreatic cystic fibrosis. Recently the introductionof tandem mass spectrometry has allowed the screening of many metabolic diseases; neverthelessmany of them do not match the minimal criteria to be included in a public healthscreening program(AU)</dc:description>
<dc:creator>Galbe Sánchez-Ventura, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Desde finales de la década de los setenta, muchos países pusieron en marcha programasde cribado metabólico neonatal encaminados al diagnóstico precoz de aquellas metabolopatíascongénitas que, detectadas en los primeros días de vida, fuesen susceptibles detratamiento. De esta manera se mejoró notablemente el pronóstico de algunas de estas enfermedades.Inicialmente, los programas incluyeron el cribado de la fenilcetonuria y del hipotiroidismocongénito, siendo ampliados posteriormente con el de la hiperplasia suprarrenalcongénita y de la fibrosis quística de páncreas. Recientemente, la introducción de laespectrometría de masas en tándem ha permitido el cribado de muchas metabolopatías, sinembargo, muchas de ellas no reúnen los criterios mínimos para ser incluidas en un programade cribado universal(AU)</dc:description>
<dc:source>Pediatr. aten. prim;11(43): 471-484, jul.-sept. 2009. tab</dc:source>
<dc:identifier>ibc-73735</dc:identifier>
<dc:title xml:lang="es">Cribado neonatal de metabolopatías</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7217^s22012</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29480^s22045</dc:subject>
<dc:subject>^d8838^s22012</dc:subject>
<dc:subject>^d8838^s22067</dc:subject>
<dc:subject>^d29480^s22066</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7217^s22016</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d8838^s22016</dc:subject>
<dc:subject>^d29480^s22074</dc:subject>
<dc:subject>^d8838^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200909</dc:date>
</metadata>
</record>
</ibecs-document>
